Voyageur Pharmaceuticals Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Voyageur Pharmaceuticals Ltd. generated cash of -$991,252, which is more than the previous year. Cash used in financing activities reached the amount of $1,136,497 last year. Net change in cash is therefore -$29,476.
Cash Flow
| 2014 | -23.65K | 0 | 0 |
|---|---|---|---|
| 2015 | -70.64K | -40.99K | 85.96K |
| 2016 | -35.07K | 0 | 642.70K |
| 2017 | -624.23K | -191.86K | 831.54K |
| 2018 | -490.45K | -224.05K | 844.37K |
| 2019 | -637.80K | -169.61K | 736.12K |
| 2020 | -272.19K | -151.79K | 351.33K |
| 2021 | -1.65M | -432.07K | 2.89M |
| 2022 | -1.71M | -274.15K | 1.21M |
| 2023 | -991.25K | -174.72K | 1.13M |
VM.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.56K | 812.96K | 2.96K | 75.61K | 146.91K | 17.04K | 1.60K | 89.35K | 160.00K | 183.66K |
Operating activities | ||||||||||
Net income | -1.39M | -1.75M | -2.05M | -1.13M | -552.29K | -555.86K | -670.75K | -52.32K | -1.48K | -94.46K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.18K | 9.21K | 2.24K | 1.48K | 2.12K | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 234.02K | 207.29K | 737.6K | 279.25K | 5.31K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 234.02K | 207.29K | 737.6K | 279.25K | 5.31K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 17.65K | -28.87K | 1.5K | -16.83K | 1.35K | 12.32K | 0 | 71 | 0 |
Inventories | 0 | -610 | 168 | 232 | -10.11K | 90.27K | 0 | 0 | 0 | 0 |
Accounts payable | 0 | -192.45K | -81.87K | 165.80K | 146.79K | 20.12K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -991.25K | -1.71M | -1.65M | -272.19K | -637.80K | -490.45K | -624.23K | -35.07K | -70.64K | -23.65K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -174 | -282.91K | -432.07K | -161.93K | -1.82K | -320.99K | -532.98K | 0 | -42.25K | 0 |
Acquisitions Net | 0 | 8.76K | 0 | 0 | 0 | 0 | 54.28K | 0 | 0 | 0 |
Cash generated by investing activities | -174.72K | -274.15K | -432.07K | -151.79K | -169.61K | -224.05K | -191.86K | 0 | -40.99K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 1.19M | 1.24M | 2.30M | 154.7K | 793.24K | 909.81K | 736.85K | 642.70K | 85.96K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -16.55K | -18.85K | -3.73K | 22.38K | -8.12K | -4.53K | 0 | 0 | 0 |
Cash used in financing activities | 1.13M | 1.21M | 2.89M | 351.33K | 736.12K | 844.37K | 831.54K | 642.70K | 85.96K | 0 |
Net Change In Cash | -29.47K | -781.40K | 810K | -72.64K | -71.30K | 129.86K | 15.44K | 607.63K | -70.64K | -23.65K |
Cash at end of period | 2.08K | 31.56K | 812.96K | 2.96K | 75.61K | 146.91K | 17.04K | 696.99K | 89.35K | 160.00K |